2002 Fiscal Year Final Research Report Summary
Study of Reversal agents of chloroquine resistant Plasmodium falciparum
| Project/Area Number |
13670254
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
寄生虫学(含医用動物学)
|
|---|
| Research Institution | Kyorin University School of Medicine |
|---|
Principal Investigator |
KARUKI Kosuke Kyorin University School of Medicine, Department of Infectious Diseases, Snior Lecturer, 医学部, 講師 (30286421)
|
|---|
| Project Period (FY) |
2001 – 2002
|
| Keywords | Plasmodium falciparum / Chloroquine / Reversal agents / Cepharanthin / N276 |
|---|
| Research Abstract |
The agents which may reverse chloroquine sensitivity of Plasmodium falciparum are investigated. Cepaharnthin a mixture of cepharanthine (CE), isotetrandrine (IT), berbamine (BE), homoalomoline (HO), cepharanoline (CO), cycleanine (CY) showed remarkable reversal effect against K1 strain. Fifty percent of inhibition concentration are CP 333.8^^+__-103.6nM, CE 1018.0^^+__-138.2, IT 169.8^^+__-27.4, BE 485.8^^+__-46.2, HO 1489.8^^+__-299.7, CO 1015.9^^+__-95.7, CY 3767.9^^+__-1993.8. Alkaloids except for CY are similar structure despite the results divided three groups in term of efficacy. There are relatively low IC_<50> group such as IT, BE, high group such as CE, HO, CO and CY which sowed no efficacy to malaria parasite. The reversal effect is highest with CP compare with single alkaloids as 15 times whilst CE 2, IT 9, BE 4, HO 2, CO 3, CY 1.5 times. CP the mixture of these 6 alkaloids showed most effective combination and expected for clinical use in future. The novel P-glycoprotein inhibitor N276 series developed by Nikken Kagaku Co, had been investigated also as same method using cepharanthin. N-276-15 showed same value of reversal as same as standard chemosensitizer Verapamkl. N-276-5, 17, 26 and 27 showed no reversal with K1 strain. Those two experiments suggested that P-glycoprotein may not be strongly related with chloroquine resistant mechanism of Plasmodium falciparum.
|
